{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T21:50:03Z","timestamp":1788731403783,"version":"build-2803163510"},"reference-count":64,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAD"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>SARS-CoV-2 is a life-threatening virus in the world. Scientific evidence\nindicates that this pathogen will emerge again in the future. Although the current vaccines have a\npivotal role in the control of this pathogen, the emergence of new variants has a negative impact\non their effectiveness.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Therefore, it is urgent to consider the protective and safe vaccine against all subcoronavirus\nspecies and variants based on the conserved region of the virus. Multi-epitope peptide\nvaccine (MEV), comprised of immune-dominant epitopes, is designed by immunoinformatic tools\nand it is a promising strategy against infectious diseases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Spike glycoprotein and nucleocapsid proteins from all coronavirus species and variants\nwere aligned and the conserved region was selected. Antigenicity, toxicity, and allergenicity\nof epitopes were checked by a proper server. To robust the immunity of the multi-epitope\nvaccine, cholera toxin b (CTB) and three HTL epitopes of tetanus toxin fragment C (TTFrC)\nwere linked at the N-terminal and C-terminal of the construct, respectively. Selected epitopes\nwith MHC molecules and the designed vaccines with Toll-like receptors (TLR-2 and TLR-4)\nwere docked and analyzed. The immunological and physicochemical properties of the designed\nvaccine were evaluated. The immune responses to the designed vaccine were simulated. Furthermore,\nmolecular dynamic simulations were performed to study the stability and interaction\nof the MEV-TLRs complexes during simulation time by NAMD (Nanoscale molecular dynamic)\nsoftware. Finally, the codon of the designed vaccine was optimized according to Saccharomyces\nboulardii.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The conserved regions of spike glycoprotein and nucleocapsid protein were gathered.\nThen, safe and antigenic epitopes were selected. The population coverage of the designed vaccine\nwas 74.83%. The instability index indicated that the designed multi-epitope was stable (38.61).\nThe binding affinity of the designed vaccine to TLR2 and TLR4 was -11.4 and -11.1, respectively.\nThe designed vaccine could induce humoral and cellular immunity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In silico analysis showed that the designed vaccine is a protective multi-epitope vaccine\nagainst SARS-CoV-2 variants.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573409919666230612125440","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T09:48:17Z","timestamp":1686649697000},"page":"274-290","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Designing a Multi-epitope Vaccine against the SARS-CoV-2 Variant based\non an Immunoinformatics Approach"],"prefix":"10.2174","volume":"20","author":[{"given":"Ibrahim","family":"Farhani","sequence":"first","affiliation":[{"name":"Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical\nSciences, Gorgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahad","family":"Yamchi","sequence":"additional","affiliation":[{"name":"Department of Plant Breeding and Biotechnology, Gorgan University of Agricultural\nScience and Natural Resources, Gorgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid","family":"Madanchi","sequence":"additional","affiliation":[{"name":"Drug Design and Bioinformatics Unit, Department of Medical\nBiotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Khazaei","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical\nSciences, Gorgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Behrouzikhah","sequence":"additional","affiliation":[{"name":"Department of Medical\nMicrobiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidreza","family":"Abbasi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical\nSciences, Gorgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Salehi","sequence":"additional","affiliation":[{"name":"Department of Medical\nGenetics, School of Advanced Technologies in Medicine, Golestan University of Medical Sciences, Gorgan,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufar","family":"Moradi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Golestan University of Medical\nSciences, Gorgan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Sanami","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, School of Advanced Technologies, Shahrekord University of Medical\nSciences, Shahrekord, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/07391102.2020.1792347","volume":"40","author":"Samad A.","year":"2022","unstructured":"Samad A.; Ahammad F.; Nain Z.; Alam R.; Imon R.R.; Hasan M.; Rahman M.S.; Designing a multi-epitope vaccine against SARS-CoV-2: An immunoinformatics approach. J Biomol Struct Dyn 2022,40(1),14-30","journal-title":"J Biomol Struct Dyn"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/14760584.2022.2077196","volume":"21","author":"Vashishtha V.M.","year":"2022","unstructured":"Vashishtha V.M.; Kumar P.; Responding to new challenges: Is there a need to relook and revise our COVID-19 vaccination strategy? Expert Rev Vaccines 2022,21(8),1015-1018","journal-title":"Expert Rev Vaccines"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-020-2608-y","volume":"586","author":"van Doremalen N.","year":"2020","unstructured":"van Doremalen N.; Lambe T.; Spencer A.; Belij-Rammerstorfer S.; Purushotham J.N.; Port J.R.; Avanzato V.A.; Bushmaker T.; Flaxman A.; Ulaszewska M.; Feldmann F.; Allen E.R.; Sharpe H.; Schulz J.; Holbrook M.; Okumura A.; Meade-White K.; P\u00e9rez-P\u00e9rez L.; Edwards N.J.; Wright D.; Bissett C.; Gilbride C.; Williamson B.N.; Rosenke R.; Long D.; Ishwarbhai A.; Kailath R.; Rose L.; Morris S.; Powers C.; Lovaglio J.; Hanley P.W.; Scott D.; Saturday G.; de Wit E.; Gilbert S.C.; Munster V.J.; ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques. Nature 2020,586(7830),578-582","journal-title":"Nature"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1056\/NEJMoa2110345","volume":"385","author":"Thomas S.J.","year":"2021","unstructured":"Thomas S.J.; Moreira, E.D., Jr; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J.L.; P\u00e9rez Marc, G.; Polack, F.P.; Zerbini, C.; Bailey, R.; Swanson, K.A.; Xu, X.; Roychoudhury, S.; Koury, K.; Bouguermouh, S.; Kalina, W.V.; Cooper, D.; Frenck, R.W., Jr; Hammitt, L.L.; T\u00fcreci, \u00d6.; Nell, H.; Schaefer, A.; \u00dcnal, S.; Yang, Q.; Liberator, P.; Tresnan, D.B.; Mather, S.; Dormitzer, P.R.; \u015eahin, U.; Gruber, W.C.; Jansen, K.U. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months. N Engl J Med 2021,385(19),1761-1773","journal-title":"N Engl J Med"},{"key":"ref=5","author":"Baum U.","year":"2022","unstructured":"Baum U.; Poukka E.; Leino T.; Kilpi T.; Nohynek H.; Palmu A.A.; High vaccine effectiveness against severe Covid-19 in the elderly in Finland before and after the emergence of Omicron. MedRxiv 2022","journal-title":"MedRxiv"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s41591-021-01527-y","volume":"27","author":"Choi A.","year":"2021","unstructured":"Choi A.; Koch M.; Wu K.; Chu L.; Ma L.; Hill A.; Nunna N.; Huang W.; Oestreicher J.; Colpitts T.; Bennett H.; Legault H.; Paila Y.; Nestorova B.; Ding B.; Montefiori D.; Pajon R.; Miller J.M.; Leav B.; Carfi A.; McPhee R.; Edwards D.K.; Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: An interim analysis. Nat Med 2021,27(11),2025-2031","journal-title":"Nat Med"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3390\/vaccines10040575","volume":"10","author":"Mengesha B.","year":"2022","unstructured":"Mengesha B.; Asenov A.G.; Hirsh-Raccah B.; Amir O.; Pappo O.; Asleh R.; Severe acute myocarditis after the third (booster) dose of mRNA COVID-19 vaccination. Vaccines 2022,10(4),575","journal-title":"Vaccines"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1056\/NEJMp2118468","volume":"386","author":"Morens D.M.","year":"2022","unstructured":"Morens D.M.; Taubenberger J.K.; Fauci A.S.; Universal coronavirus vaccines-an urgent need. N Engl J Med 2022,386(4),297-299","journal-title":"N Engl J Med"},{"key":"ref=9","first-page":"219","volume":"74","author":"Ranjbar M.M.","year":"2019","unstructured":"Ranjbar M.M.; Ebrahimi M.M.; Shahsavandi S.; Farhadi T.; Mirjalili A.; Tebianian M.; Motedayen M.H.; Novel applications of immuno-bioinformatics in vaccine and bio-product developments at research institutes. Arch Razi Inst 2019,74(3),219-233","journal-title":"Arch Razi Inst"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2174\/1570164617666190919120140","volume":"17","author":"Goumari M.M.","year":"2020","unstructured":"Goumari M.M.; Farhani I.; Nezafat N.; Mahmoodi S.; Multi-Epitope Vaccines (MEVs), as a Novel Strategy Against Infectious Diseases. Curr Proteomics 2020,17(5),354-364","journal-title":"Curr Proteomics"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1006\/biol.2001.0297","volume":"29","author":"Sette A.","year":"2001","unstructured":"Sette A.; Livingston B.; McKinney D.; Appella E.; Fikes J.; Sidney J.; Newman M.; Chesnut R.; The development of multi-epitope vaccines: epitope identification, vaccine design and clinical evaluation. Biologicals 2001,29(3-4),271-276","journal-title":"Biologicals"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10989-018-9698-5","volume":"25","author":"Farhani I.","year":"2019","unstructured":"Farhani I.; Nezafat N.; Mahmoodi S.; Designing a novel multi-epitope peptide vaccine against pathogenic Shigella spp. based immunoinformatics approaches. Int J Pept Res Ther 2019,25(2),541-553","journal-title":"Int J Pept Res Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.immuni.2010.10.002","volume":"33","author":"Coffman R.L.","year":"2010","unstructured":"Coffman R.L.; Sher A.; Seder R.A.; Vaccine adjuvants: putting innate immunity to work. Immunity 2010,33(4),492-503","journal-title":"Immunity"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3390\/vaccines3030579","volume":"3","author":"Stratmann T.","year":"2015","unstructured":"Stratmann T.; Cholera toxin subunit B as adjuvant\u2013an accelerator in protective immunity and a break in autoimmunity. Vaccines 2015,3(3),579-596","journal-title":"Vaccines"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1128\/IAI.68.5.2503-2512.2000","volume":"68","author":"Lee J.J.","year":"2000","unstructured":"Lee J.J.; Sinha K.A.; Harrison J.A.; de Hormaeche R.D.; Riveau G.; Pierce R.J.; Capron A.; Wilson R.A.; Khan C.M.A.; Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase. Infect Immun 2000,68(5),2503-2512","journal-title":"Infect Immun"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"54","DOI":"10.7774\/cevr.2015.4.1.54","volume":"4","author":"Lim Y.T.","year":"2015","unstructured":"Lim Y.T.; Vaccine adjuvant materials for cancer immunotherapy and control of infectious disease. Clin Exp Vaccine Res 2015,4(1),54-58","journal-title":"Clin Exp Vaccine Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"35856","DOI":"10.1039\/D0RA06849G","volume":"10","author":"Kumar N.","year":"2020","unstructured":"Kumar N.; Sood D.; Chandra R.; Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework. RSC Advances 2020,10(59),35856-35872","journal-title":"RSC Advances"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1590\/1678-4162-9167","volume":"70","author":"Roos T.B.","year":"2018","unstructured":"Roos T.B.; Avila L.F.C.; Sturbelle R.T.; Leite F.L.L.; Fischer G.; Leite F.P.L.; Saccharomyces boulardii modulates and improves the immune response to Bovine Herpesvirus type 5 Vaccine. Arq Bras Med Vet Zootec 2018,70(2),375-381","journal-title":"Arq Bras Med Vet Zootec"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.3748\/wjg.v16.i18.2202","volume":"16","author":"McFarland L.V.","year":"2010","unstructured":"McFarland L.V.; Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 2010,16(18),2202-2222","journal-title":"World J Gastroenterol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"e112660","DOI":"10.1371\/journal.pone.0112660","volume":"9","author":"Hudson L.E.","year":"2014","unstructured":"Hudson L.E.; Fasken M.B.; McDermott C.D.; McBride S.M.; Kuiper E.G.; Guiliano D.B.; Corbett A.H.; Lamb T.J.; Functional heterologous protein expression by genetically engineered probiotic yeast Saccharomyces boulardii. PLoS One 2014,9(11),e112660","journal-title":"PLoS One"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/bioinformatics\/btm076","volume":"23","author":"Papadopoulos J.S.","year":"2007","unstructured":"Papadopoulos J.S.; Agarwala R.; COBALT: Constraint-based alignment tool for multiple protein sequences. Bioinformatics 2007,23(9),1073-1079","journal-title":"Bioinformatics"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2105-7-153","volume":"7","author":"Bui H.H.","year":"2006","unstructured":"Bui H.H.; Sidney J.; Dinh K.; Southwood S.; Newman M.J.; Sette A.; Predicting population coverage of T-cell epitope-based diagnostics and vaccines. BMC Bioinformatics 2006,7(1),153","journal-title":"BMC Bioinformatics"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"D405","DOI":"10.1093\/nar\/gku938","volume":"43","author":"Vita R.","year":"2015","unstructured":"Vita R.; Overton J.A.; Greenbaum J.A.; Ponomarenko J.; Clark J.D.; Cantrell J.R.; Wheeler D.K.; Gabbard J.L.; Hix D.; Sette A.; Peters B.; The immune epitope database (IEDB) 3.0. Nucleic Acids Res 2015,43(D1),D405-D412","journal-title":"Nucleic Acids Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","volume":"199","author":"Jurtz V.","year":"2017","unstructured":"Jurtz V.; Paul S.; Andreatta M.; Marcatili P.; Peters B.; Nielsen M.; NetMHCpan-4.0: Improved peptide\u2013MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J Immunol 2017,199(9),3360-3368","journal-title":"J Immunol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"263952","DOI":"10.1155\/2013\/263952","volume":"2013","author":"Dhanda S.K.","year":"2013","unstructured":"Dhanda S.K.; Gupta S.; Vir P.; Raghava G.; Prediction of IL4 inducing peptides. Clin Dev Immunol 2013,2013,263952","journal-title":"Clin Dev Immunol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0014-5793(90)80535-Q","volume":"276","author":"Kolaskar A.S.","year":"1990","unstructured":"Kolaskar A.S.; Tongaonkar P.C.; A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990,276(1-2),172-174","journal-title":"FEBS Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1186\/1471-2105-9-514","volume":"9","author":"Ponomarenko J.","year":"2008","unstructured":"Ponomarenko J.; Bui H.H.; Li W.; Fusseder N.; Bourne P.E.; Sette A.; Peters B.; ElliPro: A new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics 2008,9(1),514","journal-title":"BMC Bioinformatics"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1471-2105-8-4","volume":"8","author":"Doytchinova I.A.","year":"2007","unstructured":"Doytchinova I.A.; Flower D.R.; VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 2007,8(1),4","journal-title":"BMC Bioinformatics"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1007\/s00894-014-2278-5","volume":"20","author":"Dimitrov I.","year":"2014","unstructured":"Dimitrov I.; Bangov I.; Flower D.R.; Doytchinova I.; AllerTOP v.2\u2014a server for in silico prediction of allergens. J Mol Model 2014,20(6),2278","journal-title":"J Mol Model"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e73957","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"Gupta S.","year":"2013","unstructured":"Gupta S.; Kapoor P.; Chaudhary K.; Gautam A.; Kumar R.; Raghava G.P.S.; Raghava G.P.; In silico approach for predicting toxicity of peptides and proteins. PLoS One 2013,8(9),e73957","journal-title":"PLoS One"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"Chen X.","year":"2013","unstructured":"Chen X.; Zaro J.L.; Shen W.C.; Fusion protein linkers: Property, design and functionality. Adv Drug Deliv Rev 2013,65(10),1357-1369","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=32","first-page":"571-607","author":"Gasteiger E.","year":"2005","unstructured":"Gasteiger E.; Hoogland C.; Gattiker A.; Wilkins M. R.; Appel R. D.; Bairoch A.; Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook 2005,571-607","journal-title":"The proteomics protocols handbook"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/jmbi.1999.3091","volume":"292","author":"Jones D.T.","year":"1999","unstructured":"Jones D.T.; Protein secondary structure prediction based on position- specific scoring matrices 1 1Edited by G. Von Heijne. J Mol Biol 1999,292(2),195-202","journal-title":"J Mol Biol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nmeth.3213","volume":"12","author":"Yang J.","year":"2015","unstructured":"Yang J.; Yan R.; Roy A.; Xu D.; Poisson J.; Zhang Y.; The I-TASSER Suite: protein structure and function prediction. Nat Methods 2015,12(1),7-8","journal-title":"Nat Methods"},{"key":"ref=35","first-page":"1","volume":"2","author":"Shin W-H.","year":"2014","unstructured":"Shin W-H.; Lee G.R.; Heo L.; Lee H.; Seok C.; Prediction of protein structure and interaction by GALAXY protein modeling programs. Bio Design 2014,2(1),1-11","journal-title":"Bio Design"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/pro.5560020916","volume":"2","author":"Colovos C.","year":"1993","unstructured":"Colovos C.; Yeates T.O.; Verification of protein structures: Patterns of nonbonded atomic interactions. Protein Sci 1993,2(9),1511-1519","journal-title":"Protein Sci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"e1002829","DOI":"10.1371\/journal.pcbi.1002829","volume":"8","author":"Kringelum J.V.","year":"2012","unstructured":"Kringelum J.V.; Lundegaard C.; Lund O.; Nielsen M.; Reliable B cell epitope predictions: Impacts of method development and improved benchmarking. PLOS Comput Biol 2012,8(12),e1002829","journal-title":"PLOS Comput Biol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Yan Y.","year":"2020","unstructured":"Yan Y.; Tao H.; He J.; Huang S.Y.; The HDOCK server for integrated protein\u2013protein docking. Nat Protoc 2020,15(5),1829-1852","journal-title":"Nat Protoc"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1093\/bioinformatics\/btw514","volume":"32","author":"Xue L.C.","year":"2016","unstructured":"Xue L.C.; Rodrigues J.P.; Kastritis P.L.; Bonvin A.M.; Vangone A.; PRODIGY: A web server for predicting the binding affinity of protein\u2013protein complexes. Bioinformatics 2016,32(23),3676-3678","journal-title":"Bioinformatics"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1261\/rna.2309906","volume":"12","author":"Babendure J.R.","year":"2006","unstructured":"Babendure J.R.; Babendure J.L.; Ding J.H.; Tsien R.Y.; Control of mammalian translation by mRNA structure near caps. RNA 2006,12(5),851-861","journal-title":"RNA"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"e9862","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"Rapin N.","year":"2010","unstructured":"Rapin N.; Lund O.; Bernaschi M.; Castiglione F.; Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system. PLoS One 2010,5(4),e9862","journal-title":"PLoS One"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/jcc.20289","volume":"26","author":"Phillips J.C.","year":"2005","unstructured":"Phillips J.C.; Braun R.; Wang W.; Gumbart J.; Tajkhorshid E.; Villa E.; Chipot C.; Skeel R.D.; Kal\u00e9 L.; Schulten K.; Scalable molecular dynamics with NAMD. J Comput Chem 2005,26(16),1781-1802","journal-title":"J Comput Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"33-38, 27-28","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"Humphrey W.","year":"1996","unstructured":"Humphrey W.; Dalke A.; Schulten K.; VMD: Visual molecular dynamics. J Mol Graph 1996,14(1),33-38, 27-28","journal-title":"J Mol Graph"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"198114","DOI":"10.1016\/j.virusres.2020.198114","volume":"288","author":"Kaur S.P.","year":"2020","unstructured":"Kaur S.P.; Gupta V.; COVID-19 Vaccine: A comprehensive status report. Virus Res 2020,288,198114","journal-title":"Virus Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e7386","DOI":"10.7759\/cureus.7386","volume":"12","author":"Valencia D.N.","year":"2020","unstructured":"Valencia D.N.; Brief review on COVID-19: The 2020 pandemic caused by SARS-CoV-2. Cureus 2020,12(3),e7386","journal-title":"Cureus"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3389\/fimmu.2018.01043","volume":"9","author":"De Brito R.C.F.","year":"2018","unstructured":"De Brito R.C.F.; Cardoso J.M.D.O.; Reis L.E.S.; Vieira J.F.; Mathias F.A.S.; Roatt B.M.; Aguiar-Soares R.D.D.O.; Ruiz J.C.; Resende D.M.; Reis A.B.; Peptide vaccines for leishmaniasis. Front Immunol 2018,9,1043","journal-title":"Front Immunol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2147\/DDDT.S95691","volume":"10","author":"Mahendran R.","year":"2016","unstructured":"Mahendran R.; Jeyabaskar S.; Michael D.; Vincent Paul A.; Sitharaman G.; Computer-aided vaccine designing approach against fish pathogens Edwardsiella tarda and Flavobacterium columnare using bioinformatics softwares. Drug Des Devel Ther 2016,10,1703-1714","journal-title":"Drug Des Devel Ther"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.csbj.2021.04.061","volume":"19","author":"Nagy A.","year":"2021","unstructured":"Nagy A.; Alhatlani B.; An overview of current COVID-19 vaccine platforms. Comput Struct Biotechnol J 2021,19,2508-2517","journal-title":"Comput Struct Biotechnol J"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"169","DOI":"10.7774\/cevr.2020.9.2.169","volume":"9","author":"Yurina V.","year":"2020","unstructured":"Yurina V.; Coronavirus epitope prediction from highly conserved region of spike protein. Clin Exp Vaccine Res 2020,9(2),169-173","journal-title":"Clin Exp Vaccine Res"},{"key":"ref=50","first-page":"1","author":"Masmouei B.","year":"2020","unstructured":"Masmouei B.; Harorani M.; Bazrafshan M-R.; Karimi Z.; COVID-19: hyperinflammatory syndrome and hemoadsorption with CytoSorb. Blood Purif 2020,1","journal-title":"Blood Purif"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.meegid.2017.04.009","volume":"51","author":"Saadi M.","year":"2017","unstructured":"Saadi M.; Karkhah A.; Nouri H.R.; Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches. Infect Genet Evol 2017,51,227-234","journal-title":"Infect Genet Evol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1080\/07391102.2020.1850357","volume":"40","author":"Ayyagari V.S.","year":"2022","unstructured":"Ayyagari V.S.; T C, V.; K, A.P.; Srirama, K. Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: An immunoinformatics approach. J Biomol Struct Dyn 2022,40(7),2963-2977","journal-title":"J Biomol Struct Dyn"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imu.2016.09.004","volume":"5","author":"Gurung A.B.","year":"2016","unstructured":"Gurung A.B.; Bhattacharjee A.; Ali M.A.; Exploring the physicochemical profile and the binding patterns of selected novel anticancer Himalayan plant derived active compounds with macromolecular targets. Informatics in Medicine Unlocked 2016,5,1-14","journal-title":"Informatics in Medicine Unlocked"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40545-022-00424-0","volume":"15","author":"Merchant H.A.","year":"2022","unstructured":"Merchant H.A.; Why COVID vaccines for young children (5\u201311 years) are not essential at this moment in time? J Pharm Policy Pract 2022,15(1),25","journal-title":"J Pharm Policy Pract"},{"key":"ref=55","author":"Feng Y.","year":"2020","unstructured":"Feng Y.; Qiu M.; Zou S.; Li Y.; Luo K.; Chen R.; Sun Y.; Wang K.; Zhuang X.; Zhang S.; Multi-epitope vaccine design using an immunoinformatics approach for 2019 novel coronavirus in China (SARS-CoV-2). bioRxiv 2020","journal-title":"bioRxiv"},{"key":"ref=56","volume":"373","author":"Merchant H.","year":"2021","unstructured":"Merchant H.; Myocarditis followed by CoViD-19 vaccines: A cause for concern or a reversible minor effect. BMJ 2021,373(1244)","journal-title":"BMJ"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.amjmed.2021.08.037","volume":"135","author":"Baker P.J.","year":"2022","unstructured":"Baker P.J.; Advantages of an oral vaccine to control the COVID-19 pandemic. Am J Med 2022,135(2),133-134","journal-title":"Am J Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3389\/fmicb.2018.00723","volume":"9","author":"Bagherpour G.","year":"2018","unstructured":"Bagherpour G.; Ghasemi H.; Zand B.; Zarei N.; Roohvand F.; Ardakani E.M.; Azizi M.; Khalaj V.; Oral administration of recombinant Saccharomyces boulardii expressing ovalbumin-CPE fusion protein induces antibody response in mice. Front Microbiol 2018,9,723","journal-title":"Front Microbiol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s13238-015-0164-2","volume":"6","author":"Wang S.","year":"2015","unstructured":"Wang S.; Liu H.; Zhang X.; Qian F.; Intranasal and oral vaccination with protein-based antigens: Advantages, challenges and formulation strategies. Protein Cell 2015,6(7),480-503","journal-title":"Protein Cell"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"e59822","DOI":"10.1371\/journal.pone.0059822","volume":"8","author":"Gloudemans A.K.","year":"2013","unstructured":"Gloudemans A.K.; Plantinga M.; Guilliams M.; Willart M.A.; Ozir-Fazalalikhan A.; van der Ham A.; Boon L.; Harris N.L.; Hammad H.; Hoogsteden H.C.; Yazdanbakhsh M.; Hendriks R.W.; Lambrecht B.N.; Smits H.H.; The mucosal adjuvant cholera toxin B instructs non-mucosal dendritic cells to promote IgA production via retinoic acid and TGF-\u03b2. PLoS One 2013,8(3),e59822","journal-title":"PLoS One"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"578382","DOI":"10.3389\/fphar.2020.578382","volume":"11","author":"Di Natale C.","year":"2020","unstructured":"Di Natale C.; La Manna S.; De Benedictis I.; Brandi P.; Marasco D.; Perspectives in peptide-based vaccination strategies for syndrome coronavirus 2 pandemic. Front Pharmacol 2020,11,578382","journal-title":"Front Pharmacol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1016\/j.vaccine.2019.06.044","volume":"37","author":"Hewitt J.S.","year":"2019","unstructured":"Hewitt J.S.; Karuppannan A.K.; Tan S.; Gauger P.; Halbur P.G.; Gerber P.F.; De Groot A.S.; Moise L.; Opriessnig T.; A prime-boost concept using a T-cell epitope-driven DNA vaccine followed by a whole virus vaccine effectively protected pigs in the pandemic H1N1 pig challenge model. Vaccine 2019,37(31),4302-4309","journal-title":"Vaccine"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1046\/j.1365-2796.2003.01140.x","volume":"253","author":"Liu M.A.","year":"2003","unstructured":"Liu M.A.; DNA vaccines: A review. J Intern Med 2003,253(4),402-410","journal-title":"J Intern Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/vaccines2030515","volume":"2","author":"Li W.","year":"2014","unstructured":"Li W.; Joshi M.; Singhania S.; Ramsey K.; Murthy A.; Peptide vaccine: Progress and challenges. Vaccines 2014,2(3),515-536","journal-title":"Vaccines"}],"container-title":["Current Computer-Aided Drug Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666230612125440","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/217891\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573409919666230612125440","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T07:56:23Z","timestamp":1698738983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/217891\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573409919666230612125440","relation":{},"ISSN":["1573-4099"],"issn-type":[{"value":"1573-4099","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-11-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}